Avexis, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Avexis, Inc.

Sort by

Viewing results 1‒4 of 4

LexHealthcare
Alcon/Novartis: eye inflection Premium content
...Mr Narasimhan has splashed out on expensive bolt-on acquisitions to bolster its portfolio of new treatments, including almost $9bn a year ago on AveXis, a US specialist in spinal muscular atrophy....
April 9, 2019
European companies
Novartis slims down with $25bn spin-off of Alcon eyecare business
...Since taking over as Novartis CEO in February, Mr Narasimhan has announced the GSK transaction and spent $8.7bn buying AveXis, a US specialist in spinal muscular atrophy, a childhood wasting disease....
June 29, 2018
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
US & Canadian companies
Bats Global Markets set to test water over second listing attempt
...In the first quarter, the value raised through US IPOs was the lowest since the first quarter of 2009 and only four companies — biotech groups Editas Medicine, BeiGene and AveXis; and energy acquisition...
April 1, 2016
US & Canadian companies
Torrid first quarter for US initial public offerings
...The value raised through US IPOs was also the lowest since the first quarter of 2009 and only four companies — biotech groups Editas Medicine, BeiGene and AveXis, and energy acquisition vehicle Silver Run...
March 30, 2016

Previous pagePage 1 of 1Next page